Picture of Egetis Therapeutics AB (publ) logo

EGTX Egetis Therapeutics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.

May 5 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

EGETIS ANNOUNCES GRANT OF PATENT FOR MCT8 DEFICIENCY COMPOSITION IN U.S.

Source text: ID:nMFN2yg4fv

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Egetis Therapeutics AB (publ)

See all news